Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 2519204)

Published in Am J Physiol Heart Circ Physiol on June 20, 2008

Authors

Christopher J Clarke1, Simon Forman, James Pritchett, Vasken Ohanian, Jacqueline Ohanian

Author Affiliations

1: Cardiovascular Research Group, School of Clinical and Laboratory Science, Univ. of Manchester, Core Technology Facility (3floor 46 Grafton St., Manchester M13 9NT, UK.

Articles citing this

Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium (2009) 1.65

A distinct pool of phosphatidylinositol 4,5-bisphosphate in caveolae revealed by a nanoscale labeling technique. Proc Natl Acad Sci U S A (2009) 1.25

Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: a novel insight into vascular dysfunction. Hypertension (2008) 1.15

O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1. Hypertension (2009) 0.96

Function and expression of ryanodine receptors and inositol 1,4,5-trisphosphate receptors in smooth muscle cells of murine feed arteries and arterioles. J Physiol (2012) 0.92

Augmented S-nitrosylation contributes to impaired relaxation in angiotensin II hypertensive mouse aorta: role of thioredoxin reductase. J Hypertens (2011) 0.79

Age-related remodeling of small arteries is accompanied by increased sphingomyelinase activity and accumulation of long-chain ceramides. Physiol Rep (2014) 0.79

STIM1/Orai1 contributes to sex differences in vascular responses to calcium in spontaneously hypertensive rats. Clin Sci (Lond) (2012) 0.78

Multiple factors influence calcium synchronization in arterial vasomotion. Biophys J (2012) 0.78

Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries. Br J Pharmacol (2013) 0.78

Expression of secreted phospholipase A2-Group IIA correlates with prognosis of gastric adenocarcinoma. Oncol Lett (2015) 0.77

Articles cited by this

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev (2003) 9.32

Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem (2001) 6.42

Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature (2000) 6.04

Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev (2000) 5.13

Phosphoinositide regulation of the actin cytoskeleton. Annu Rev Physiol (2002) 4.56

A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol (2001) 3.86

Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol (2003) 3.83

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55

Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle. Circ Res (2006) 2.79

Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50

Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem (1986) 2.33

Membrane binding and subcellular targeting of C2 domains. Biochim Biophys Acta (2006) 2.20

Regulation of inositol lipid-specific phospholipase cdelta by changes in Ca2+ ion concentrations. Biochem J (1997) 1.60

The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest (2002) 1.60

Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J Biol Chem (1992) 1.53

A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities. EMBO J (1995) 1.53

Phospholipase C activity is enhanced in skin fibroblasts obtained from patients with essential hypertension. J Hypertens (2003) 1.43

Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol (2002) 1.33

Replacements of single basic amino acids in the pleckstrin homology domain of phospholipase C-delta1 alter the ligand binding, phospholipase activity, and interaction with the plasma membrane. J Biol Chem (1998) 1.32

Phospholipase Cbeta2 binds to and inhibits phospholipase Cdelta1. J Biol Chem (2004) 1.30

A PLCdelta1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization. Genes Cells (2004) 1.14

Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J (2006) 1.14

Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem (1996) 1.11

Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J Biol Chem (1999) 1.10

Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc Med (2005) 1.10

Membrane targeting of C2 domains of phospholipase C-delta isoforms. J Biol Chem (2001) 1.07

Caveolae and sarcoplasmic reticular coupling in smooth muscle cells of pressurised arteries: the relevance for Ca2+ oscillations and tone. Cardiovasc Res (2006) 1.05

Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol (2003) 1.03

Phospholipase Cdelta1 is required for skin stem cell lineage commitment. EMBO J (2003) 1.02

Agonist-induced production of 1,2-diacylglycerol and phosphatidic acid in intact resistance arteries. Evidence that accumulation of diacylglycerol is not a prerequisite for contraction. J Biol Chem (1990) 1.01

Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal (1997) 1.00

Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem (1996) 0.99

Caveolae-associated signalling in smooth muscle. Can J Physiol Pharmacol (2004) 0.97

Thrombin-mediated phosphoinositide hydrolysis in Chinese hamster ovary cells overexpressing phospholipase C-delta 1. J Biol Chem (1994) 0.97

Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats. Br J Pharmacol (1999) 0.95

Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J Biol Chem (1994) 0.89

Involvement of tyrosine phosphorylation in endothelin-1-induced calcium-sensitization in rat small mesenteric arteries. Br J Pharmacol (1997) 0.89

Regulation of phospholipase C-delta1 through direct interactions with the small GTPase Ral and calmodulin. J Biol Chem (2005) 0.89

Norepinephrine and endothelin activate diacylglycerol kinases in caveolae/rafts of rat mesenteric arteries: agonist-specific role of PI3-kinase. Am J Physiol Heart Circ Physiol (2007) 0.88

Role of endothelins in hypertension. Am J Ther (2007) 0.88

Activation of PLC-delta1 by Gi/o-coupled receptor agonists. Am J Physiol Cell Physiol (2004) 0.87

Enhancement of phospholipase C delta 1 activity in the aortas of spontaneously hypertensive rats. J Biol Chem (1992) 0.86

Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. Br J Pharmacol (2003) 0.85

Subcellular localization of phospholipase C isoforms in vascular smooth muscle. Biochim Biophys Acta (2002) 0.83

PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization. Am J Physiol Lung Cell Mol Physiol (2005) 0.83

Noradrenaline stimulation of the phosphoinositide system: evidence for a novel hydrophobic inositol-containing compound in resistance arterioles. Br J Pharmacol (1988) 0.83

Phospholipase C delta-type consists of three isozymes: bovine PLCdelta2 is a homologue of human/mouse PLCdelta4. Biochem Biophys Res Commun (2004) 0.82

Alterations of mRNA levels of alpha 1-adrenoceptor subtypes with maturation and ageing in different rat blood vessels. Clin Exp Pharmacol Physiol (1997) 0.81

Hypotensive effect associated with a phospholipase C-delta 1 gene mutation in the spontaneously hypertensive rat. Biochem Biophys Res Commun (1992) 0.80

Articles by these authors

alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension (2005) 1.59

Evidence in favor of a calcium-sensing receptor in arterial endothelial cells: studies with calindol and Calhex 231. Circ Res (2005) 1.34

Role of the actin cytoskeleton in G-protein-coupled receptor activation of PYK2 and paxillin in vascular smooth muscle. Hypertension (2005) 1.15

Stromal-derived factor 1 signalling regulates radial and tangential migration in the developing cerebral cortex. Dev Neurosci (2008) 1.01

MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation. Am J Physiol Endocrinol Metab (2008) 0.93

Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res (2003) 0.93

Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries. Am J Physiol Heart Circ Physiol (2004) 0.93

Noradrenaline-induced paxillin phosphorylation, ERK activation and MEK-regulated contraction in intact rat mesenteric arteries. J Vasc Res (2002) 0.89

Norepinephrine and endothelin activate diacylglycerol kinases in caveolae/rafts of rat mesenteric arteries: agonist-specific role of PI3-kinase. Am J Physiol Heart Circ Physiol (2007) 0.88

Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase. J Vasc Res (2012) 0.79

YIA 03-09 NORADRENERGIC RECEPTOR FUNCTION IN HEALTHY AND OBESE PERIVASCULAR ADIPOSE TISSUE. J Hypertens (2016) 0.75

YIA 03-09 NORADRENERGIC RECEPTOR FUNCTION IN HEALTHY AND OBESE PERIVASCULAR ADIPOSE TISSUE. J Hypertens (2016) 0.75